Amandine Perrin

432 total citations
21 papers, 295 citations indexed

About

Amandine Perrin is a scholar working on Rheumatology, Genetics and Immunology. According to data from OpenAlex, Amandine Perrin has authored 21 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Genetics and 4 papers in Immunology. Recurrent topics in Amandine Perrin's work include Parathyroid Disorders and Treatments (3 papers), Lysosomal Storage Disorders Research (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Amandine Perrin is often cited by papers focused on Parathyroid Disorders and Treatments (3 papers), Lysosomal Storage Disorders Research (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Amandine Perrin collaborates with scholars based in Germany, United Kingdom and France. Amandine Perrin's co-authors include Christoph Kampmann, Michael Beck, Ricardo Reisin, Pablo García‐Pavía, Ulrich‐Axel Bommer, M J Clemens, Sergei Lobov, Philip R. Dash, Androulla Elia and Werner Aberer and has published in prestigious journals such as JAMA, Oncogene and Journal of Allergy and Clinical Immunology.

In The Last Decade

Amandine Perrin

20 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amandine Perrin Germany 8 154 89 56 55 48 21 295
Toju Tanaka Japan 10 274 1.8× 121 1.4× 25 0.4× 106 1.9× 43 0.9× 16 417
Stephanie DeArmey United States 5 309 2.0× 105 1.2× 26 0.5× 179 3.3× 83 1.7× 9 390
Yasuyuki Fukuhara Japan 9 119 0.8× 82 0.9× 27 0.5× 50 0.9× 23 0.5× 18 351
Desnick Rj United States 9 219 1.4× 63 0.7× 17 0.3× 72 1.3× 69 1.4× 25 307
Carmela Zizzo Italy 14 384 2.5× 140 1.6× 18 0.3× 118 2.1× 122 2.5× 34 490
Cấn Thị Bích Ngọc Vietnam 6 113 0.7× 59 0.7× 14 0.3× 47 0.9× 31 0.6× 21 207
Shoshi Shpitzen Israel 11 118 0.8× 23 0.3× 12 0.2× 108 2.0× 38 0.8× 15 400
Teresa Kivisto United States 7 156 1.0× 35 0.4× 32 0.6× 26 0.5× 6 0.1× 8 376
David F. Kronn United States 7 114 0.7× 52 0.6× 14 0.3× 62 1.1× 30 0.6× 9 310
Roberto Della Casa Italy 16 139 0.9× 31 0.3× 19 0.3× 311 5.7× 89 1.9× 34 536

Countries citing papers authored by Amandine Perrin

Since Specialization
Citations

This map shows the geographic impact of Amandine Perrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amandine Perrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amandine Perrin more than expected).

Fields of papers citing papers by Amandine Perrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amandine Perrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amandine Perrin. The network helps show where Amandine Perrin may publish in the future.

Co-authorship network of co-authors of Amandine Perrin

This figure shows the co-authorship network connecting the top 25 collaborators of Amandine Perrin. A scholar is included among the top collaborators of Amandine Perrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amandine Perrin. Amandine Perrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Devanand, D. P., Thomas Wısnıewskı, Qolamreza Razlighi, et al.. (2025). Valacyclovir Treatment of Early Symptomatic Alzheimer Disease. JAMA. 335(6). 511–511.
2.
Burton, James O., Stefan H. Jacobson, Pablo Molina, et al.. (2024). #802 CENSUS-EU: a cross-sectional, study to assess the prevalence and burden of chronic kidney disease-associated pruritus in Europe. Nephrology Dialysis Transplantation. 39(Supplement_1). 1 indexed citations
3.
Vervloet, Marc, Ioannis Boletis, Ángel L.M. de Francisco, et al.. (2020). Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study. Clinical Kidney Journal. 14(7). 1770–1779. 4 indexed citations
4.
Greenbaum, Larry A., Nikola Jeck, Günter Klaus, et al.. (2020). Safety and efficacy of sucroferric oxyhydroxide in pediatric patients with chronic kidney disease. Pediatric Nephrology. 36(5). 1233–1244. 6 indexed citations
5.
Covic, Adrian, Stuart M. Sprague, Anjay Rastogi, et al.. (2020). Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study. ˜The œNephron journals/Nephron journals. 144(9). 428–439. 3 indexed citations
6.
7.
Aberer, Werner, Marcus Maurer, Laurence Bouillet, et al.. (2017). Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey. Allergy Asthma and Clinical Immunology. 13(1). 31–31. 15 indexed citations
8.
Reisin, Ricardo, Amandine Perrin, & Pablo García‐Pavía. (2017). Time delays in the diagnosis and treatment of Fabry disease. International Journal of Clinical Practice. 71(1). e12914–e12914. 57 indexed citations
9.
Maurer, Marcus, Werner Aberer, Teresa Caballero, et al.. (2017). Early Versus Late Administration of Icatibant in Patients With Hereditary Angioedema. Journal of Allergy and Clinical Immunology. 139(2). AB233–AB233. 1 indexed citations
10.
Carrera, Fernando, K-U Eckardt, Sandrine Gaillard, et al.. (2017). MP416EFFICACY OF ORAL IRON FOR TREATING IRON DEFICIENCY IN ANAEMIC PATIENTS WITH NON-DIALYSIS DEPENDENT CKD (ND-CKD). Nephrology Dialysis Transplantation. 32(suppl_3). iii581–iii581. 1 indexed citations
11.
Macdougall, Iain C., Andreas Böck, Fernando Carrera, et al.. (2017). Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial. Clinical Nephrology. 88(12). 301–310. 20 indexed citations
12.
Caballero, Teresa, Werner Aberer, Hilary Longhurst, et al.. (2017). The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries. Journal of the European Academy of Dermatology and Venereology. 31(7). 1214–1222. 21 indexed citations
13.
Kampmann, Christoph, Amandine Perrin, & Michael Beck. (2015). Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years’ treatment. Orphanet Journal of Rare Diseases. 10(1). 125–125. 93 indexed citations
14.
15.
Bommer, Ulrich‐Axel, Amandine Perrin, Philip R. Dash, et al.. (2009). Roles of the translationally controlled tumour protein (TCTP) and the double-stranded RNA-dependent protein kinase, PKR, in cellular stress responses. Oncogene. 29(5). 763–773. 39 indexed citations
16.
Perrin, Amandine. (1999). Know how. Going home after stoma surgery.. PubMed. 5(10). 26–7. 4 indexed citations
17.
Perrin, Amandine, et al.. (1993). [Freezing of solutions for parenteral usage: advantages and disadvantages. Nine month's experience at the pharmacy of the Hospital of Nancy].. PubMed. 47(6). 504–22. 5 indexed citations
18.
Manac'h, Y, Amandine Perrin, J Depondt, & Carsten R. Hamann. (1987). [Plastic surgery of aplasia of the external ear. Apropos of 65 cases].. PubMed. 104(8). 599–605. 1 indexed citations
19.
Guilbert, F, et al.. (1985). [Benign tumors and mandibular resection. The place of resection grafts in the treatment of benign tumors of the mandible].. PubMed. 86(4). 216–20. 1 indexed citations
20.
Froment, R, Amandine Perrin, R Loire, & C Dalloz. (1968). [Papyraceous right ventricule in the young adult caused by congenital dystrophy. Apropos of 2 anatomo-clinical cases and 3 clinical cases].. PubMed. 61(4). 477–503. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toju Tanaka Breakdown of academic impact, for papers by Stephanie DeArmey Breakdown of academic impact, for papers by Yasuyuki Fukuhara Breakdown of academic impact, for papers by Desnick Rj Breakdown of academic impact, for papers by Carmela Zizzo Breakdown of academic impact, for papers by Cấn Thị Bích Ngọc Breakdown of academic impact, for papers by Shoshi Shpitzen Breakdown of academic impact, for papers by Teresa Kivisto Breakdown of academic impact, for papers by David F. Kronn Breakdown of academic impact, for papers by Roberto Della Casa
Rankless by CCL
2026